Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma

Glioblastoma (GBM) is the most common primary brain tumor in adults. Despite conventional treatment, consisting of a chirurgical resection followed by concomitant radio–chemotherapy, the 5-year survival rate is less than 5%. Few risk factors are clearly identified, but women are 1.4-fold less affect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirtz, Alex, Bailly, Yann, Rech, Fabien, Pierson, Julien, Dumond, Hélène, Dubois-Pot-Schneider, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695951/
https://www.ncbi.nlm.nih.gov/pubmed/36430793
http://dx.doi.org/10.3390/ijms232214309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695951/
https://www.ncbi.nlm.nih.gov/pubmed/36430793
http://dx.doi.org/10.3390/ijms232214309

Ejemplares similares